SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-221086
Filing Date
2017-07-03
Accepted
2017-07-03 15:13:02
Documents
6
Period of Report
2017-07-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d417782d8k.htm 8-K 20347
2 EX-1.1 d417782dex11.htm EX-1.1 149561
3 EX-5.1 d417782dex51.htm EX-5.1 9128
4 EX-99.1 d417782dex991.htm EX-99.1 19310
5 GRAPHIC g417782g04k26.jpg GRAPHIC 2644
6 GRAPHIC g417782g04p68.jpg GRAPHIC 118335
  Complete submission text file 0001193125-17-221086.txt   366525
Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Filer) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36561 | Film No.: 17945341
SIC: 2834 Pharmaceutical Preparations